ahlam1399
09-20-2016, 10:55 AM
Bayer ups sales targets for top-selling ***** after Monsanto deal
FRANKFURT (Reuters) - German drugmaker Bayer said its two best-selling ***** had a higher annual peak sales potential than previously targeted, after the agreed $66 billion takeover of Monsanto stirred criticism it might neglect its pharmaceuticals business.http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=rSoiq750x8o:haUZ2Pm17ic:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=rSoiq750x8o:haUZ2Pm17ic:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=rSoiq750x8o:haUZ2Pm17ic:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=rSoiq750x8o:haUZ2Pm17ic:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=rSoiq750x8o:haUZ2Pm17ic:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/rSoiq750x8o
FRANKFURT (Reuters) - German drugmaker Bayer said its two best-selling ***** had a higher annual peak sales potential than previously targeted, after the agreed $66 billion takeover of Monsanto stirred criticism it might neglect its pharmaceuticals business.http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=rSoiq750x8o:haUZ2Pm17ic:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=rSoiq750x8o:haUZ2Pm17ic:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=rSoiq750x8o:haUZ2Pm17ic:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=rSoiq750x8o:haUZ2Pm17ic:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=rSoiq750x8o:haUZ2Pm17ic:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/rSoiq750x8o